Yahoo India Web Search

Search results

  1. Jun 20, 2024 · Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.

  2. Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

  3. May 5, 2021 · DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.

  4. Jun 28, 2022 · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options.

  5. Get the latest Jazz Pharmaceuticals PLC (JAZZ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  6. Jul 2, 2024 · JAZZ | Complete Jazz Pharmaceuticals PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  7. Dec 21, 2023 · Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2 trial (NCT05178316) evaluating JZP150, an investigational small molecule selective fatty acid amide ...

  8. Find the latest Jazz Pharmaceuticals plc (JAZZ) stock quote, history, news and other vital information to help you with your stock trading and investing.

  9. Sep 12, 2023 · As Jazz Pharmaceuticals turns the page from its long-time growth driver Xyrem and leans on a trio of newer medicines for growth, its executive roster is undergoing some changes. The company’s...

  10. 5 days ago · Jazz Pharmaceuticals is promoting Samantha Pearce, currently its senior vice president of Europe and international, to chief commercial officer as she takes the lead in running its commercial engine.